RxSight, Inc. Announces 2024 Annual Meeting of Stockholders
Ticker: RXST · Form: DEF 14A · Filed: Apr 25, 2024 · CIK: 1111485
| Field | Detail |
|---|---|
| Company | Rxsight, Inc. (RXST) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2024 |
| Risk Level | |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: Proxy Statement, Annual Meeting, Virtual Meeting, Stockholder Voting, Corporate Governance
TL;DR
<b>RxSight, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 6, 2024, urging all eligible shareholders to vote.</b>
AI Summary
RxSight, Inc. (RXST) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. The 2024 Annual Meeting of Stockholders for RxSight, Inc. will be held virtually on Thursday, June 6, 2024, at 8:00 a.m. Pacific Time. Stockholders of record as of the close of business on April 8, 2024, are eligible to participate and vote. The meeting will be conducted via live webcast at www.proxydocs.com/RXST, allowing remote attendance, question submission, and online voting. The company emphasizes that a virtual format enhances accessibility, communication, and stockholder participation while offering cost savings. Shareholders are urged to vote promptly via the Internet, phone, or by returning a proxy card, regardless of virtual attendance.
Why It Matters
For investors and stakeholders tracking RxSight, Inc., this filing contains several important signals. The shift to a virtual meeting format aims to increase stockholder engagement and participation, potentially leading to more informed decision-making. The company's emphasis on prompt voting highlights the importance of shareholder input in corporate governance and strategic direction.
Risk Assessment
Risk Level: — RxSight, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational risks disclosed.
Analyst Insight
Review the proposals and director nominations presented at the annual meeting to assess the company's governance and strategic direction.
Key Numbers
- 2024 — Annual Meeting Year (The year of the upcoming Annual Meeting of Stockholders.)
- June 6 — Meeting Date (The specific date of the virtual Annual Meeting.)
- 8:00 a.m. Pacific Time — Meeting Time (The scheduled start time for the virtual Annual Meeting.)
- April 8 — Record Date (The close of business date to determine stockholder eligibility.)
Key Players & Entities
- RxSight, Inc. (company) — Registrant and filer of the proxy statement.
- June 6, 2024 (date) — Date of the 2024 Annual Meeting of Stockholders.
- April 8, 2024 (date) — Record date for determining stockholders eligible to receive proxy materials and vote.
- www.proxydocs.com/RXST (url) — Web address for attending the virtual annual meeting.
FAQ
When did RxSight, Inc. file this DEF 14A?
RxSight, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 25, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by RxSight, Inc. (RXST).
Where can I read the original DEF 14A filing from RxSight, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by RxSight, Inc..
What are the key takeaways from RxSight, Inc.'s DEF 14A?
RxSight, Inc. filed this DEF 14A on April 25, 2024. Key takeaways: The 2024 Annual Meeting of Stockholders for RxSight, Inc. will be held virtually on Thursday, June 6, 2024, at 8:00 a.m. Pacific Time.. Stockholders of record as of the close of business on April 8, 2024, are eligible to participate and vote.. The meeting will be conducted via live webcast at www.proxydocs.com/RXST, allowing remote attendance, question submission, and online voting..
Is RxSight, Inc. a risky investment based on this filing?
Based on this DEF 14A, RxSight, Inc. presents a moderate-risk profile. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational risks disclosed.
What should investors do after reading RxSight, Inc.'s DEF 14A?
Review the proposals and director nominations presented at the annual meeting to assess the company's governance and strategic direction. The overall sentiment from this filing is neutral.
How does RxSight, Inc. compare to its industry peers?
RxSight, Inc. operates in the ophthalmic goods industry, focusing on medical devices for vision correction.
Are there regulatory concerns for RxSight, Inc.?
This filing is a Definitive Proxy Statement (DEF 14A) filed under the Securities Exchange Act of 1934, outlining corporate governance matters for the annual meeting.
Industry Context
RxSight, Inc. operates in the ophthalmic goods industry, focusing on medical devices for vision correction.
Regulatory Implications
This filing is a Definitive Proxy Statement (DEF 14A) filed under the Securities Exchange Act of 1934, outlining corporate governance matters for the annual meeting.
What Investors Should Do
- Review the proxy statement for details on proposals and director nominees.
- Ensure your shares are voted by the deadline, either online, by phone, or by mail.
- Attend the virtual annual meeting on June 6, 2024, to participate in discussions and ask questions.
Key Dates
- 2024-06-06: 2024 Annual Meeting of Stockholders — Key date for stockholders to vote and participate in company governance.
- 2024-04-08: Record Date — Determines eligibility for stockholders to receive proxy materials and vote.
Year-Over-Year Comparison
This is the initial filing for the 2024 Annual Meeting of Stockholders, following the standard proxy statement format.
Filing Stats: 4,822 words · 19 min read · ~16 pages · Grade level 10.8 · Accepted 2024-04-25 16:30:11
Filing Documents
- 2024_def14a_12312023.htm (DEF 14A) — 1036KB
- img95009157_0.jpg (GRAPHIC) — 110KB
- img95009157_1.jpg (GRAPHIC) — 68KB
- img95009157_2.jpg (GRAPHIC) — 10KB
- img95009157_3.jpg (GRAPHIC) — 10KB
- img95009157_4.jpg (GRAPHIC) — 36KB
- img95009157_5.jpg (GRAPHIC) — 34KB
- img95009157_6.jpg (GRAPHIC) — 630KB
- img95009157_7.jpg (GRAPHIC) — 243KB
- 0000950170-24-048381.txt ( ) — 2583KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 27 Processes and Procedures for Compensation Decisions 27 Summary Compensation Table 28 1 2023 Bonus Plan 29 Outstanding Equity Awards at Fiscal Year-End 30 Employment Arrangements With Our Named Executive Officers 31 Potential Payments upon Termination or Change in Control 32 401(k) Plan 33 Equity Compensation Plan Information 33 PAY VERSUS PERFORMANCE 34
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 37 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 39 Participation in February 2023 Public Offering 39 Payments to Praxis 39 Indemnification Agreements 39 Equity Grants to Executive Officers and Directors 40 OTHER MATTERS 40 Fiscal Year 2023 Annual Report and SEC Filings 40 2 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held Virtually at 8:00 a.m. Pacific Time on Thursday, June 6, 2024 This proxy statement and the form of proxy card are furnished in connection with the solicitation of proxies by our Board of Directors (the “Board”) for use at the 2024 annual meeting of stockholders of RxSight, Inc. (the “Annual Meeting”), and any postponements, adjournments or continuations thereof. The Annual Meeting will be held on Thursday, June 6, 2024 at 8:00 a.m. Pacific Time virtually via live webcast. You will be able to attend the Annual Meeting virtually by visiting www.proxydocs.com/RXST, where you will be able to listen to the meeting live, submit questions and vote online after entering the control number listed on your Notice of Internet Availability of Proxy Materials (the “Notice of Internet Availability”) or proxy card. QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING The information provided in the “question and answer” format below addresses certain frequently asked questions but is not intended to be a summary of all matters contained in this proxy statement. Please read the entire proxy statement carefully before voting your shares. Information contained on, or that can be accessed through, our website is not intended to be incorporated by reference into this proxy statement and references to our website address in this proxy statement are inactive textual references only. Why am I receiving these materials? Our Board is providing these “proxy materials” (as d